Skip to main content
SpringerLink
Log in

Biodegradable PLGA Microspheres Loaded with Ganciclovir for Intraocular Administration. Encapsulation Technique, in Vitro Release Profiles, and Sterilization Process

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The purpose of this work was to obtain a sterilized formulation consisting of biodegradable microspheres of poly (DL-lactide-co-glycolide) (PLGA) for intraocular sustained release of ganciclovir.

Methods. Microspheres were prepared using a dispersion of ganciclovir in fluorosilicone oil (FSiO) that was further dispersed in an acetone solution of PLGA [50/50 and inherent viscosity 0.41 dl/g], and emulsified in silicone oil with a surfactant. Once prepared, the formulation was exposed with an effective γ radiation dose of 2.5 megarads. The release rate data of ganciclovir from the sterilized and nonsterilized batches were compared using the similarity factor (f2).

Results. The dispersion of the drug in FSiO contributed to achieving a drug payload of up to 95% of the theoretical in the 300-500 μm microspheres. Ten mg released ganciclovir in vitroat 1.3 μg/h for the first 21 days, but decreased to ∼ 0.2 μg/h from day 25 until the end of the release study (42 days). No significant differences in the amounts of encapsulated drug (α=0.05) were observed between the sterilized and nonsterilized microspheres. Furthermore, dissolution profiles of formulations behaved similarly before and after gamma radiation exposure.

Conclusions. The technique of microsphere preparation described resulted in high ganciclovir loading (95%) and prolonged drug release. The ganciclovir formulation behaved similarly before and after the sterilization process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. D. A. Jab, C. Enger, and J. G Bartlett. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch. Ophthalmol. 107:75–80 (1989).

    Google Scholar 

  2. P. Chrisp and S. P. Clissold. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 41:104–129 (1991).

    Google Scholar 

  3. M. R. Robinson, B. W. Streeten, G. R. Hampton, E. C. Siebold, and C. Taylor-Findlay. Treatment of cytomegalovirus optic neuritis with dihydroxy propoxymethyl guanine. Am. J. Ophthalmol. 102:533–534 (1986).

    Google Scholar 

  4. D. E. Henderly, W. R. Freeman, D. M. Causey, and N. A. Rao. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology 94:425–434 (1987).

    Google Scholar 

  5. J. Orellana, S. A. Teich, A. H. Friedman, F. Lerebours, J. Winterkorn, and D. Mildvan. Combined short-and long therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U). Ophthalmology 94:831–838 (1987).

    Google Scholar 

  6. W. R. Freeman. Intraocular viral therapy. Arch. Ophthalmol. 107: 1737–1739 (1989).

    Google Scholar 

  7. K. Henry, H. Cantrill, C. Fletcher, B. J. Chinnock, and H. H. Balfour. Use of intravitreal ganciclovir (dihydroxy propoxymethylguanine) for cytomegalovirus retinitis in a patient with AIDS. Am. J. Ophthalmol. 103:17–23 (1987).

    Google Scholar 

  8. M. H. Heinemann. Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch. Ophthalmol. 107:1767–1772 (1989).

    Google Scholar 

  9. D. F. Martin, D. J. Parks, S. D. Mellow, F. L. Ferris, R. C. Walton, N. A. Remaley, E. Y. Chew, P. Ashton, M. D. Davis, and R. B. Nussenblatt. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch. Ophthalmol. 112:1531–1539 (1994).

    Google Scholar 

  10. Cytovene (ganciclovir sodium salt). In Physicians' Desk Reference, 49 Ed. Medical Economics Data Production, Montvale, New Jersey. 1995, pp 2471–2475.

  11. J. S. Cumming. Relevant anatomy and physiology of the eye. In J. R. Robinson (ed.), Ophthalmic Drug Delivery Systems, American Pharmaceutical Association, Washington DC, 1980, pp. 1–27.

    Google Scholar 

  12. S. Cohen, T. Yoshioka, M. Lucarelli, L. H. Hwang, and R. Langer. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8:713–720 (1991)

    Google Scholar 

  13. A. Zimmer and J. Kreuter. Microspheres and nanoparticles used in ocular delivery systems. Adv. Drug Deliver. Rev. 16: 61–73 (1995).

    Google Scholar 

  14. T. Moritera, Y. Ogura, Y. Honda, R. Wada, S. H. Hyon, and Y. Ikada. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. Invest. Ophth. Vis. Sci. 132:1785–1790 (1991).

    Google Scholar 

  15. G. Giordano, M. F. Refojo, and M. H. Arroyo. Sustained release of retinoic acid from microspheres of biodegradable polymer in PVR. Invest. Ophth. Vis. Sci. 34:2743–2751(1993).

    Google Scholar 

  16. R. Herrero-Vanrell, C. Alvarez-Santiago, and E. Barcia. Biodegradable microspheres loaded with dexamethasone for intravitreal administration. ARVO Abstracts. Invest. Ophth. Vis. Sci. 40:S84 (1999).

    Google Scholar 

  17. A. G. Hausberger, R. A. Kenley, and P. P. De Luca. Gamma irradiation effects on molecular weight and in-vitro degradation of poly(D,L-lactide-glycolide) microparticles. Pharm. Res. 12: 851–856 (1995).

    Google Scholar 

  18. R. Herrero Vanrell and M. F. Refojo, U.S.Patent # 5,718,922 (1998).

  19. A. Merkli, J. Heller, C. Tabatabay, and R. Gurny. Gamma sterilization of a semi-solid (ortho ester) designed for controlled drug delivery-validation and radiation effects. Pharm. Res. 11:1485–1491(1994).

    Google Scholar 

  20. USP Pharmacopoiea 24. Sterilization and Sterility Assurance.

  21. V. P. Shah, Y. Tsong, P. Sathe, and P. Liu. In vitro dissolution profile comparison–statistic and analysis of the similarity factor, f2. Pharm. Res. 15:889–895 (1998).

    Google Scholar 

  22. Y. Tsong, T. Hammestrom, S. Pradeep, and P. S. Vinod. Statistical assesment of mean differences between two dissolution data sets. Drug Inf. J. 30:1105–1112 (1996).

    Google Scholar 

  23. P. L. Ritger and N. A. Peppas. A simple equation for description of solute release I Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5: 23–36 (1987).

    Google Scholar 

  24. T. R. Tice and R. M. Gilley. Preparation of injectable controlled release microcapsules by a solvent evaporation process. J. Control. Release 2:343–350 (1985).

    Google Scholar 

  25. Q. Zhu, A. Veloso Jr., F. L. Leong, P. Geary, E. Dunkel, and M. F. Refojo. Efficacy of biodegradable microspheres loaded with ganciclovir during cytomegalovirus (CMV) infection on HS68 monolayers. Abstract. Invest. Ophth.Vis. Sci. 37:S41 (1996).

    Google Scholar 

  26. A. A. S. Veloso Jr, Q. Zhu, R. Herrero-Vanrell, and M. F. Refojo. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. Invest. Ophth. Vis. Sci. 38:665–675(1997).

    Google Scholar 

  27. K. Miyamoto, M. F. Refojo, F. I. Tolentino, G. A. Fournier, and D. M. Albert. Fluorinated oils as experimental vitreous substitutes. Arch. Ophthalmol. 104:1053–1056 (1986).

    Google Scholar 

  28. Y. Sidikaro, L. Silver, G. N. Holland, and A. E. Kreiger. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. Ophthalmology 98:129–135 (1991).

    Google Scholar 

  29. F. I. Tolentino, V. N. Cajita, H. Chung, J. Acosta, H. M. Freeman, and M. F. Refojo. High-density fluorosilicone oil in vitreous surgery. In H.M. Freeman and F.I. Tolentino (eds.), Proliferative Vitreoretinopathy (PVR), Springer-Verlag, New York, 1988, pp. 177–180.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts

    Rocio Herrero-Vanrell

  2. Departamento de Farmacia y Tecnologia Farmacéutica, Facultad de Farmacia, Universidad Complutense, Madrid, Spain

    Rocio Herrero-Vanrell & Loreto Ramirez

Authors
  1. Rocio Herrero-Vanrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Loreto Ramirez
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrero-Vanrell, R., Ramirez, L. Biodegradable PLGA Microspheres Loaded with Ganciclovir for Intraocular Administration. Encapsulation Technique, in Vitro Release Profiles, and Sterilization Process. Pharm Res 17, 1323–1328 (2000). https://doi.org/10.1023/A:1026464124412

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026464124412

Search

Navigation